Summary
Prostate cancer includes several types that differ in how fast they grow, how aggressive they act, and how doctors treat them. Knowing these differences helps patients understand PSA results, Gleason scores, treatment choices, and long-term outlook.
|
Prostate cancer is not a single disease but a group of cancer types that affect the prostate gland in different ways. Understanding the types of prostate cancer and how they differ is essential for early detection, individualized treatment planning, and long-term disease management strategies grounded in clinical evidence. This guide explores the most common and rare forms of prostate cancer, how they develop, and what patients and caregivers need to know.
Each type of prostate cancer originates in specific cells in the prostate. The growth and spread of these cancers can vary widely by type.
For example, acinar adenocarcinoma is more common and typically progresses slowly. In contrast, rare types like ductal adenocarcinoma, small cell carcinoma, or squamous cell carcinoma tend to be much more aggressive and may spread faster.
Understanding the distinct behaviors of each cancer type enables individuals to interpret warning signs, PSA levels, and Gleason scores more effectively, all of which are critical tools in diagnosis and treatment planning. This insight also supports the assessment of the risk of metastasis to other organs, such as bones or lymph nodes, which significantly influences both prognosis and treatment strategy.
What Is the Prostate and Why Does It Matter?
The prostate is a small, walnut-sized gland located below the bladder and in front of the rectum. It produces prostate fluid, an essential part of semen. The gland surrounds the tube that carries urine (urethra), so any changes in size or structure can affect urination and reproductive health. Cells in the prostate can mutate over time, leading to different types of cancer.
The Most Common Type: Acinar Adenocarcinoma
What It Is
Acinar adenocarcinoma accounts for over 90% of all prostate cancer cases. This type originates in the prostate glandular cells, which secrete prostate fluid. It often grows slowly but can grow and spread if not caught early.
How It’s Diagnosed
PSA levels: Elevated prostate-specific antigen (PSA) can signal abnormal prostate activity.
Digital rectal exam (DRE): Used to feel for lumps or changes.
Biopsy and Gleason score: The Gleason score rates the aggressiveness of cancer based on how abnormal the cells appear.
Treatment Options
Active surveillance (for slow-growing tumors)
Radiation therapy
Surgery
Hormone therapy to block cancer-fueling hormones
Less Common but Aggressive: Ductal Adenocarcinoma
What It Is
Ductal adenocarcinoma is rarer and more aggressive. It originates in the ducts of the prostate and tends to grow faster than acinar adenocarcinoma.
Key Differences
May not show elevated PSA levels
More likely to spread to parts of the body like the bladder or rectum
Detected through biopsy and imaging
Treatment
Often requires a combination of surgery, radiation, and hormone therapy due to its aggressive nature.
Rare but Serious: Transitional Cell Carcinoma
What It Is
This cancer typically starts in the bladder but can also start in the prostate, specifically in the urethra and surrounding tissues.
Characteristics
Can mimic bladder cancer symptoms
Affects the tube that carries urine
High risk of spreading to other organs
Treatment
Surgical removal of affected tissues
Drug-based cancer treatment
Radiation therapy
Small Cell and Large Cell Carcinomas
What They Are
These are hormone-related tumors, meaning they develop in hormone-producing cells. They are extremely rare but very aggressive.
Small cell carcinoma grows rapidly and often spreads before detection
Large cells are less common but follow similar patterns
Detection and Treatment
Often not detected by PSA testing
Require immediate drug-based cancer treatment and radiation
Squamous Cell Carcinoma
What It Is
This type develops in the flat cells that line the prostate gland. It does not produce PSA, making early detection difficult.
Symptoms and Risks
Rapid growth and spread
Resistance to hormone therapy
Treatment Options
Surgery
Radiation
Limited response to traditional hormone-based therapies
Comparing the Types of Prostate Cancer
| Type of Cancer | Commonality | Aggressiveness | PSA Detection | Treatment Approaches |
|---|---|---|---|---|
| Acinar Adenocarcinoma | Most common | Variable | Yes | Surveillance, Surgery, Hormone Therapy |
| Ductal Adenocarcinoma | Less common | High | Sometimes | Surgery, Radiation, Hormone Therapy |
| Transitional Cell Carcinoma | Rare | High | No | Surgery, Drug-based Treatment, Radiation |
| Small Cell Carcinoma | Extremely rare | Very high | No | Drug-based Treatment, Radiation |
| Squamous Cell Carcinoma | Extremely rare | Very high | No | Surgery, Radiation |
The Role of the Gleason Score
The Gleason score helps classify the aggressiveness of types of prostate cancer. Scores range from 6 (least aggressive) to 10 (most aggressive). A high Gleason score often indicates that the cancer is more likely to grow and spread rapidly.
Gleason 6–7: Low to intermediate risk
Gleason 8–10: High risk, needs urgent treatment
Understanding PSA and Prostate Health
Regular monitoring of PSA levels and undergoing screening tests such as the DRE can help detect abnormalities early, even when symptoms are absent. PSA levels are especially useful for tracking acinar adenocarcinoma, the most common form.
When and Why to Seek Medical Advice
If you experience any of the following, seek medical attention:
Frequent urination, especially at night
Difficulty urinating or interrupted flow
Blood in urine or semen
Pain in the lower back or pelvis
These symptoms may be linked to types of cancer affecting the prostate or other prostate conditions like benign prostatic hyperplasia.
Stay Proactive About Prostate Health
Increasing awareness about the various types of prostate cancer plays a vital role in promoting timely screenings and medical evaluations. A deeper understanding of how these cancers develop and differ enables men to pursue early diagnosis and evidence-based treatment strategies tailored to their individual risk profiles.
What You Can Do:
Know your family history
Schedule annual checkups
Watch for urinary and pelvic symptoms
Ask your doctor about PSA testing and Gleason score evaluation
Your Next Step: Talk to a Specialist
If you’re concerned about prostate health, the Onco Life Centre in Kuala Lumpur offers expert guidance, early detection tools, and advanced treatment options. From PSA testing to treatment planning, our team is here to help you understand and manage all types of cancer affecting the prostate.
Visit us today at Lot 3.1, Level 3, Wisma Life Care, 5 Jalan Kerinchi, Bangsar South, 59200 Kuala Lumpur, Malaysia.
